1. Use of Contemporary Protease Inhibitors and Risk of Incident Chronic Kidney Disease in Persons With Human Immunodeficiency Virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study.
- Author
-
Ryom, Lene, Lundgren, Jens Dilling, Reiss, Peter, Kirk, Ole, Law, Matthew, Ross, Mike, Morlat, Phillip, Fux, Christoph Andreas, Fontas, Eric, Wit, Stephane De, Monforte, Antonella D'Arminio, El-Sadr, Wafaa, Phillips, Andrew, Hatleberg, Camilla Ingrid, Sabin, Caroline, Mocroft, Amanda, Group, Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study, Dilling Lundgren, Jens, Andreas Fux, Christoph, and De Wit, Stephane
- Subjects
ANTI-HIV agents ,CHRONIC kidney failure ,HIV ,PROTEASE inhibitors ,ACQUISITION of data ,HIV infection complications ,COMPARATIVE studies ,HIV infections ,LONGITUDINAL method ,RESEARCH methodology ,MEDICAL cooperation ,RESEARCH ,RISK assessment ,EVALUATION research ,DISEASE incidence ,HIV protease inhibitors - Abstract
Background: It is unclear whether use of contemporary protease inhibitors pose a similar risk of chronic kidney disease (CKD) as use of older protease inhibitors.Methods: Participants in the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study were followed up until the earliest occurrence of CKD, the last visit plus 6 months, or 1 February 2016. Adjusted Poisson regression was used to assess associations between CKD and the use of ritonavir-boosted atazanavir (ATV/r) or ritonavir-boosted darunavir (DRV/r).Results: The incidence of CKD (10.0/1000 person-years of follow-up; 95% confidence interval, 9.5-10.4/1000 person-years of follow-up) increased gradually with increasing exposure to ATV/r, but the relation was less clear for DRV/r. After adjustment, only exposure to ATV/r (adjusted incidence rate ratio, 1.4; 95% confidence interval, 1.2-1.6), but not exposure to DRV/r (1.0; .8-1.3), remained significantly associated with CKD.Conclusion: While DRV/r use was not significantly associated with CKD an increasing incidence with longer ATV/r use was confirmed. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF